0000899243-20-023234.txt : 20200821
0000899243-20-023234.hdr.sgml : 20200821
20200821182526
ACCESSION NUMBER: 0000899243-20-023234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200820
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hall Steven Edward
CENTRAL INDEX KEY: 0001602732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 201124366
MAIL ADDRESS:
STREET 1: 15001 BARNHARDT CT
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-20
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001602732
Hall Steven Edward
C/O LILLY VENTURES
333 N. ALABAMA ST., SUITE 350
INDIANAPOLIS
IN
46204
1
0
0
0
Stock Option (Right to Buy)
20.00
2020-08-20
4
A
0
40127
0.00
A
2030-08-19
Common Stock
40127
40127
D
The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on the date of the Registration Statement Effectiveness.
/s/ Bruce Jacobs, as Attorney-in-Fact
2020-08-21